Real-world improvement in ultra-low-dose thoracic computed tomography scores, systemic inflammatory markers and patient-reported outcome measures after elexacaftor/tezacaftor/ivacaftor treatment.

ERJ Open Res · 2025 · PMC12134916 · PMID 40470159

Europe PMC DOI

hedged sentence

0.2252

closest p · 4.5× alpha

0.2252

boldest claim

The sentences

did not reach statistical significancep=0.2252not close (p > 0.1)

antibiotic days reduced from 4.333 to zero, but the adjusted p-value did not reach statistical significance (p=0.2252).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.